Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Traws Pharma Inc TRAW

Healthcare
Traws Pharma, Inc., formerly Onconova Therapeutics, Inc., is a virology and oncology company. The Company is engaged in developing antivirals for influenza, COVID and other respiratory infections and narazaciclib. Its proprietary portfolio includes, TRX100 (viroksavir), TRX01 (travaltrevir), and Narazaciclib. Viroksavir is a cap-dependent endonuclease inhibitor for influenza. Travaltrevir is a... see more

Recent & Breaking News (NDAQ:TRAW)

Onconova Therapeutics, Inc. Reports Third Quarter 2014 Financial and Operational Results

GlobeNewswire November 13, 2014

Onconova Announces Ten Presentations at the 2014 ASH Annual Meeting

GlobeNewswire November 6, 2014

Onconova Therapeutics, Inc. to Present at Rodman & Renshaw 16th Annual Global Investment Conference

GlobeNewswire September 3, 2014

Onconova Therapeutics, Inc. Reports Second Quarter 2014 Financial and Operational Results

GlobeNewswire August 13, 2014

Onconova Therapeutics, Inc. Announces Timing for Second Quarter 2014 Financial Results and Conference Call

GlobeNewswire August 6, 2014

Onconova Therapeutics, Inc. Reports First Quarter 2014 Financial and Operational Results

GlobeNewswire May 12, 2014

Onconova Therapeutics, Inc. Announces Timing for First Quarter 2014 Financial Results and Conference Call

GlobeNewswire May 6, 2014

Onconova Development Programs Highlighted in Seven Presentations at AACR Annual Meeting

GlobeNewswire April 7, 2014

Onconova Therapeutics, Inc. Reports Fourth Quarter and Year-End 2013 Financial Results and Outlines Key Objectives for 2014

GlobeNewswire March 10, 2014

Onconova Therapeutics, Inc. Announces Timing for Fourth Quarter and Year-End 2013 Financial Results and Conference Call

GlobeNewswire March 4, 2014

Onconova Therapeutics, Inc. to Present at the Cowen and Company 34th Annual Health Care Conference

GlobeNewswire February 26, 2014

Onconova Sinks on Disappointing Phase 3 Results; Arris Enterprises beats Zacks Consensus Estimate

Accesswire February 21, 2014

Onconova Loses 40 Percent of Its Value as Cancer Drug Fails Again

Equities.com February 20, 2014

Onconova Therapeutics (ONTX) pantsed by the market after poor rigerostib phase 3 results

Stockhouse Editorial February 20, 2014

Onconova Announces Results From Phase 3 ONTIME Trial of Rigosertib in Higher Risk Myelodysplastic Syndromes (MDS)

GlobeNewswire February 19, 2014

Onconova Therapeutics, Inc. to Present at 2014 Leerink Global Healthcare Conference

GlobeNewswire February 11, 2014

Onconova Therapeutics, Inc. to Present at the 16th Annual BIO CEO & Investor Conference

Globe Newswire February 6, 2014

Onconova Therapeutics, Inc. to Host Webcast Regarding Insights Into Rigosertib Mechanism of Action With Scientific Founder, Dr. E. Premkumar Reddy

Globe Newswire January 17, 2014

Onconova Therapeutics, Inc. to Present at the 32nd Annual J.P. Morgan Healthcare Conference

Globe Newswire January 6, 2014

Onconova Announces Results of Interim Analysis of Metastatic Pancreatic Cancer Study

Globe Newswire December 17, 2013